SEC
IRWD icon

Seven Eight Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Seven Eight Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29,843
Closed -$370K – 523
2022
Q4 		$370K Buy
+29,843
New +$339K 0.1% 272
2022
Q2 		– Sell
-15,104
Closed -$190K – 510
2022
Q1 		$190K Sell
15,104
-3,257
-18% -$37.3K 0.03% 496
2021
Q4 		$214K Sell
18,361
-48,509
-73% -$595K 0.04% 408
2021
Q3 		$873K Buy
+66,870
New +$864K 0.08% 336

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Seven Eight Capital's IRWD Position: Q1 2023 in Review

Seven Eight Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2023, closing a stake of 29,843 shares — an estimated $370K sold.

Seven Eight Capital first reported a position in IRWD in Q3 2021 and held it in 4 quarters. The position peaked at $873K in Q3 2021. 254 funds tracked by Wall St. Rank hold IRWD as of Q1 2023.

  • Seven Eight Capital reported no remaining Ironwood Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Seven Eight Capital sold 29,843 Ironwood Pharmaceuticals shares in Q1 2023, an estimated $370K.
  • Seven Eight Capital first reported a position in Ironwood Pharmaceuticals in Q3 2021 and held it in 4 quarters.
  • Seven Eight Capital's Ironwood Pharmaceuticals position peaked at $873K in Q3 2021.
  • 254 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2023.

Based on Seven Eight Capital's 13F filing for Q1 2023, filed 15 May 2023.